LETTER FROM THE MEDTRONIC DIABETES CMO
OUR JOURNEY TOGETHER:
HELPING YOUR PATIENTS LIVE WITH OPTIMAL DIABETES CARE
BY FRANCINE RATNER KAUFMAN, MD
Welcome to In the Know
, Medtronic Diabetes and Bayer HealthCare’s eNewsletter created especially for diabetes educators. The mission of In the Know
is to partner with educators and product trainers to help all of our mutual patients achieve optimal outcomes.
As educators, you are on the front lines every day, assessing, teaching, managing, and supporting patients. So you know first-hand that diabetes control is a lifelong journey—not a destination. My colleagues and I are honored to travel that road with you to support you and your patients.
It was very important to us that In the Know
not only be written by and for educators, but that it also be led by diabetes educator guest editors and Advisory Board members with deep experience and a passion for what they do. We are very pleased to introduce Laurel Messer, RN, MPH, CDE, as In the Know’s
first guest editor and a member of our Advisory Board
Laurel, an accomplished diabetes educator and clinical research nurse at The Barbara Davis Center for Childhood Diabetes in Aurora, Colo., works with pediatric and adult patients and has conducted extensive research in type 1 diabetes, insulin pump therapy, the use of CGM and artificial pancreas device systems, and more. She also has contributed significantly to the popular Pink Panther
books for pediatric patient education. To learn more about Laurel and her goals, please read her Editor’s Note
and full bio below.
Joining Laurel on In the Know’s Advisory Board
are esteemed colleagues from varied areas of diabetes education, who each bring extensive experience and valuable perspectives to their roles.
The goal of In the Know
is to give you the tools and practical, actionable advice and information that you need to maximize your patients’ use of the technological advances that we offer.
We are focused not only on providing you with engaging educational content but also on fostering the exchange of information—and we can always accomplish more together.
At Medtronic and Bayer, our responsibility to you and your patients doesn’t end—it begins—with the initiation of pump therapy. We promise that we will be here to support you and your patients if they encounter challenges on that lifelong journey to control their disease. Likewise, we like to think of your patients’ successes as our successes too—and we are proud to celebrate right along with you.
My colleagues and I are motivated each and every day by a common vision we share with you—a world in which the burden of diabetes is reduced, and where the patients we serve are healthy and well. We remain committed to ongoing innovation as we work to deliver on the next steps in artificial pancreas technology. In the Know
is a tool to help keep us all connected as we work toward our common goals—together.